Quick10K

⚲

Compuware Corp

Filings

10-Q	2021-03-31	Filed 2021-05-13
10-K	2020-12-31	Filed 2021-03-30
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-12
10-Q	2020-03-31	Filed 2020-06-26
10-K	2019-12-31	Filed 2020-03-20
10-Q	2019-09-30	Filed 2019-11-12
10-Q	2019-06-30	Filed 2019-08-13
10-Q	2019-03-31	Filed 2019-05-13
10-K	2018-12-31	Filed 2019-03-22
10-Q	2018-09-30	Filed 2018-11-13
10-Q	2018-06-30	Filed 2018-08-13
10-Q	2018-03-31	Filed 2018-05-14
S-1	2018-01-12	Public Filing
10-K	2017-12-31	Filed 2018-04-02
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-14
10-Q	2017-03-31	Filed 2017-05-08
10-Q	2017-03-31	Filed 2017-05-08
10-K	2016-12-31	Filed 2017-04-04
10-Q	2016-09-30	Filed 2016-11-07
10-Q	2016-06-30	Filed 2016-07-27
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-03-30
10-Q	2015-09-30	Filed 2015-11-16
10-Q	2015-06-30	Filed 2015-10-02
10-Q	2015-03-31	Filed 2015-08-31
10-Q	2014-09-30	Filed 2015-08-31
10-Q	2014-06-30	Filed 2015-08-31
10-Q	2014-03-31	Filed 2015-08-31
10-K	2013-12-31	Filed 2015-08-31
10-Q	2013-09-30	Filed 2015-08-31
10-K	2013-06-30	Filed 2015-08-31
10-Q	2013-06-30	Filed 2015-08-31
10-Q	2013-03-31	Filed 2015-08-31
10-K	2012-12-31	Filed 2015-08-31
10-Q	2012-09-30	Filed 2015-08-31
10-Q	2012-06-30	Filed 2012-08-20
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-29
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-04-13
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-08-16
10-Q	2010-03-31	Filed 2010-05-13
10-K	2009-12-31	Filed 2010-03-31

Reports

8-K	2020-05-05
8-K	2019-05-06
8-K	2018-05-22
8-K	2018-02-16
8-K	2017-12-28

Compuware Corp Financials

CPWR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	33	19	1	2	1	5	1	0	1	11	1	0	44	91	6	4	5	0	0	1	14	27	21	425	142	75	18	8	77	28	16
Accounts Receivable	2	3	14	17	18	11	6	0	4	2	0	0	0								0
Inventory	63	0
PP&E	26	22	19	11	8	7	5	0	4	3	2	0	0									891	921	894	916	924	923	1	0	0	0
Assets	126	55	41	31	28	25	12	0	9	16	2	0	44	91	6	7	7	0	0	1	14	917	944	1,344	1,083	1,025	962	9	88	28	16
Accounts Payable	390	388	394	397	405	410	425	407	432	448	440	445	422	447	417	489	474	444	453	186	202			6,846				8,876
Long-Term Debt	314	309	307	302	300	309	302	300	300	300	342	337	320				300				0	642	3,967	5,049	5,567	6,110	5,698	6,610	6,878	6,862	6,851
Liabilities	1,118	1,157	1,213	1,291	1,335	1,338	1,357	1,384	1,367	1,392	1,392	1,406	1,391	1,430	1,404	1,518	1,563	1,630	1,689	1,459	1,561	11,851	11,729	11,854	12,480	13,644	14,420	17,778	17,974	18,357	18,829
Stockholders' Equity	-992	-1,101	-1,172	-1,260	-1,306	-1,313	-1,345	-1,384	-1,358	-1,376	-1,390	-1,405	-1,347	-1,338	-1,398	-1,511	-1,556	-1,630	-1,689	-1,458	-1,547	-10,934	-10,785	-10,510	-11,397	-12,619	-13,459	-17,769	-17,886	-18,329	-18,812


Income Statement ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	79	74	49	58	56	78	27	2	9	8	4	1	2	2	2	0	0	0	0	0		0	0	0	0	0	0		0	0	0
Cost of Revenue	26	95	5	6	9	26	5	0	10	40	3	0	0	0	0	0	0	0	0	0	0
Gross Profit	53	-21	44	51	214	51	23	2	-1	75	1	1	2	2	2	0	0	0	0	0
R&D	44	25	26	25	55	26	20		8		0	0	0	0	0	0	0
SG&A	45	37	51	40	37	53	28	0	19	23	17	2	-0	9	17	20	21	21	231	22	10	231	99	1,818	227	321	91		60	70	84
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0		0	0	0
Net Income	-69	-109	-71	-47	-49	-56	-49		-30	-185	-30	-16	58	-55	-60	-164	-69	-78	-269	-61	-89	-797	-2,251	-3,978	-952	-1,333	-1,001		-232	-690	-694


Cash Flow ($'000)	2011-09-30	2011-12-31	2012-03-31	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-34	-55		1	5	-4	-44			-11	-0		-9	-85	-52	-37	-72	-30	-20			-324		-835	-542	-177		-235	-105	-160
Cash Investing		0	0							-63				100			0	0					-30		-22	-8	0		0	0	0
Cash Financing		20	37			-1	0	0	0		0	0	0			50	38	68	30	21			349		574	483	120		304	56	149